Triple immune-staining of CD11c, MHC-II IA/IE and F4/80 results showed that CHA treated G422-bearing mice contained more CD11c+ and MHC-II IA/IE+ double positive cells in F4/80+ macrophages infiltrating in tumor tissue than the control group (Fig. 5C,D). Here, ITGAX is linked to neoplasm.